As of 2025-12-15, the Intrinsic Value of Biophytis SA (ALBPS.PA) is -1.12 EUR. This ALBPS.PA valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.08 EUR, the upside of Biophytis SA is -1,503.94%.
Based on its market price of 0.08 EUR and our intrinsic valuation, Biophytis SA (ALBPS.PA) is overvalued by 1,503.94%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -1.12 - -1.12 | -1.12 | -1,503.94% |
| P/E | (0.67) - (1.26) | (0.96) | -1304.2% |
| DDM - Stable | (0.87) - (2.96) | (1.92) | -2492.6% |
| DDM - Multi | (0.87) - (2.52) | (1.32) | -1747.2% |
| Market Cap (mil) | 3.17 |
| Beta | -0.14 |
| Outstanding shares (mil) | 39.56 |
| Enterprise Value (mil) | 8.29 |
| Market risk premium | 5.82% |
| Cost of Equity | 15.22% |
| Cost of Debt | 5.00% |
| WACC | 7.08% |